Monthly Archives: March 2010
US Advisory Committee to Re-evaluate Vivus’s Weight Loss Drug in July
Submitted by Prakash Sharma on Sat, 03/27/2010 – 12:04 The US advisory committee will be re-evaluating Vivus Inc.’s Qnexa, obesity drug in July. This revision will be done prior to the predicted FDA’s action in October, announced the company on … Continue reading
FDA considers drug that lowers blood pressure, cholesterol and weight
(NBC) - We’ve always been taught there’s no such thing as a quick fix for obesity, but that may soon change. Peter Tam is the president of Mountain View-based Vivus, a Silicon Valley biotech company with what could be the next blockbuster … Continue reading
Vivus wins three new US patents for obesity drug
Vivus, a biopharmaceutical company, has announced the issuance of three additional patents by the US Patent and Trademark Office, or USPTO, covering Qnexa, an investigational new drug candidate for the treatment of obesity. The three new patents are the second, … Continue reading